The relationship of Plasmodium falciparum humeral immunity with HIV-1 immunosuppression and treatment efficacy in Zambia

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Van Geertruyden, Jean Pierre ^a,e   Van Eijk, Erika ^b   Yosaatmadja, Francisca ^c   Kasongo, Webster ^d   Mulenga, Modest ^d   D'Alessandro, Umberto ^e   Rogerson, Stephen ^c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d TROPICAL DISEASES RESEARCH CENTRE   (Zambia)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; ARTEMETHER PLUS BENFLUMETOL; FANSIDAR; IMMUNOGLOBULIN G; MEROZOITE SURFACE PROTEIN 1; ANTIMALARIAL AGENT; MEMBRANE ANTIGEN; PARASITE ANTIGEN; PROTOZOON ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALARIA; MALE; MEROZOITE; PARASITE IMMUNITY; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME; ZAMBIA; ANIMAL; BLOOD; CASE CONTROL STUDY; FLOW CYTOMETRY; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; MALARIA FALCIPARUM; MIDDLE AGED; PARASITOLOGY;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; ANTIMALARIALS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; MALE; MEROZOITE SURFACE PROTEIN 1; MIDDLE AGED; PLASMODIUM FALCIPARUM; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT; ZAMBIA;

EID: 72349098976     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-258     Document Type: Article

References (42)

1. Immunity to malaria: more questions than answers. J Langhorne FM Ndungu AM Sponaas K Marsh, Nat Immunol 2008 9 725 732 10.1038/ni.f.205 18563083
2. The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. K Artavanis-Tsakonas JE Tongren EM Riley, Clin Exp Immunol 2003 133 145 152 10.1046/j.1365-2249.2003.02174.x 12869017
3. Immune effector mechanisms in malaria. K Marsh S Kinyanjui, Parasite Immunol 2006 28 51 60 10.1111/j.1365-3024.2006.00808.x 16438676
4. Protein trafficking to apical organelles of malaria parasites - building an invasion machine. LM Kats BM Cooke RL Coppel CG Black, Traffic 2008 9 176 186 18047549
5. An introduction to the structural organization of parasitic protozoa. W de Souza, Curr Pharm Des 2008 14 822 838 10.2174/138161208784041123 18473832
6. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. I Nebie A Diarra A Ouedraogo I Soulama EC Bougouma AB Tiono R Chilengi M Theisen D Dodoo E Remarque S Bosomprah P Milligan SB Sirima, Infect Immun 2008 76 759 766 10.1128/IAI.01147-07 18070896
7. The pathogenic basis of malaria. LH Miller DI Baruch K Marsh OK Doumbo, Nature 2002 415 673 679 10.1038/415673a 11832955
8. Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens. MF Ofori D Dodoo T Staalsoe JA Kurtzhals K Koram T Theander BD Akanmori L Hviid, Infect Immun 2002 70 2982 2988 10.1128/IAI.70.6.2982-2988.2002 12010988 (Pubitemid 34564157)
9. Variant surface antigens, virulence genes and the pathogenesis of malaria. KW Deitsch L Hviid, Trends Parasitol 2004 20 562 566 10.1016/j.pt.2004.09.002 15522665
10. A family affair: var genes, PfEMP1 binding, and malaria disease. SM Kraemer JD Smith, Curr Opin Microbiol 2006 9 374 380 10.1016/j.mib.2006.06.006 16814594
11. Malaria and HIV: a silent alliance. JP Van geertruyden U D'Alessandro, Trends Parasitol 2007 23 465 467 10.1016/j.pt.2007.08.006 17822960
12. Interactions between HIV and malaria in non-pregnant adults: evidence and implications. K Hewitt R Steketee V Mwapasa J Whitworth N French, AIDS 2006 20 1993 2004 10.1097/01.aids.0000247572.95880.92 17053345
13. HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. JP Van geertruyden M Mulenga L Mwananyanda V Chalwe F Moerman R Chilengi W Kasongo C Van Overmeir JC Dujardin R Colebunders L Kestens U D'Alessandro, J Infect Dis 2006 194 917 925 10.1086/507310 16960779
14. Increased risk for severe malaria in HIV-1-infected adults, Zambia. V Chalwe JP Van geertruyden D Mukwamataba J Menten J Kamalamba M Mulenga U D'Alessandro, Emerg Infect Dis 2009 15 749 10.3201/eid1505.081009 19402961
15. Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl. C Mouala M Guiguet S Houze F Damond G Pialoux N Viget D Costagliola J Le Bras S Matheron FHDH-ANRS CO4 Clinical Epidemiology Group, AIDS 2009 23 1997 2004 10.1097/QAD.0b013e32832f4215 19654499
16. HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. J Keen L Serghides K Ayi SN Patel J Ayisi A van Eijk R Steketee V Udhayakumar KC Kain, PLoS Med 2007 4 181 10.1371/journal.pmed.0040181 17535103
17. Impact of human immunodeficiency virus infection in pregnant women on variant-specific immunity to malaria. EG Dembo V Mwapasa J Montgomery AG Craig KA Porter SR Meshnick ME Molyneux SJ Rogerson, Clin Vaccine Immunol 2008 15 617 621 10.1128/CVI.00378-07 18199738
18. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. AM Mount V Mwapasa SR Elliott JG Beeson E Tadesse VM Lema ME Molyneux SR Meshnick SJ Rogerson, Lancet 2004 363 1860 1867 10.1016/S0140-6736(04)16354-X 15183624
19. Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso. F Migot JB Ouedraogo J Diallo H Zampan B Dubois T Scott-Finnigan PT Sanou P Deloron, Parasite Immunol 1996 18 333 339 10.1046/j.1365-3024.1996.d01-116.x 9229386
20. Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. M Mulenga JP Van geertruyden L Mwananyanda V Chalwe F Moerman R Chilengi C Van Overmeir JC Dujardin U D'Alessandro, Malar J 2006 5 73 10.1186/1475-2875-5-73 16923176
21. World Health Organization, Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria WHO. Geneva 2003
22. Affordable CD4(+) T-cell counts on 'single-platform' flow cytometers I. Primary CD4 gating. G Janossy I Jani W Gohde, Br J Haematol 2000 111 1198 1208 10.1046/j.1365-2141.2000.02433.x 11167762
23. Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria. JD Smith AG Craig N Kriek D Hudson-Taylor S Kyes T Fagan R Pinches DI Baruch CI Newbold LH Miller, Proc Natl Acad Sci USA 2000 97 1766 1771 10.1073/pnas.040545897 10677532
24. Variant antigens and endothelial receptor adhesion in Plasmodium falciparum. JP Gardner RA Pinches DJ Roberts CI Newbold, Proc Natl Acad Sci USA 1996 93 3503 3508 10.1073/pnas.93.8.3503 8622966
25. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets. JG Beeson EJ Mann SR Elliott VM Lema E Tadesse ME Molyneux GV Brown SJ Rogerson, J Infect Dis 2004 189 540 551 10.1086/381186 14745713
26. Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria. L Hviid JA Kurtzhals BQ Goka JO Oliver-Commey FK Nkrumah TG Theander, Infect Immun 1997 65 4090 4093 9317012
27. CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria. JP Van geertruyden M Mulenga W Kasongo K Polman R Colebunders L Kestens U D'Alessandro, J Acquir Immune Defic Syndr 2006 43 363 367 10.1097/01.qai.0000243125.98024.da 17079994
28. Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. OJ Akpogheneta NO Duah KK Tetteh S Dunyo DE Lanar M Pinder DJ Conway, Infect Immun 2008 76 1748 1755 10.1128/IAI.01333-07 18212081
29. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. F Miedema AJ Petit FG Terpstra JK Schattenkerk F de Wolf BJ Al M Roos JM Lange SA Danner J Goudsmit, J Clin Invest 1988 82 1908 1914 10.1172/JCI113809 2974045
30. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection. CC John AM Moormann DC Pregibon PO Sumba MM McHugh DL Narum DE Lanar MD Schluchter JW Kazura, Am J Trop Med Hyg 2005 73 222 228 16014863
31. Profiling the antibody immune response against blood stage malaria vaccine candidates. JC Gray PH Corran E Mangia MW Gaunt Q Li KK Tetteh, Clin Chem 2007 53 1244 1253 10.1373/clinchem.2006.081695 17510307
32. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. FH Osier G Fegan SD Polley L Murungi F Verra KK Tetteh SD Polley DJ Conway AA Holder T Bacarese-Hamilton EM Riley A Crisanti, Infect Immun 2008 76 2240 2248 10.1128/IAI.01585-07 18316390
33. Malaria pathophysiology. NJ White N Landau P Gautret, Malaria: parasite biology, pathogenesis and protection. Washington D.C, Sherman IW, 1998 378 379
34. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. WG Metzger DM Okenu DR Cavanagh JV Robinson KA Bojang HA Weiss JS McBride BM Greenwood DJ Conway, Parasite Immunol 2003 25 307 312 10.1046/j.1365-3024.2003.00636.x 14507328
35. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. SD Polley T Mwangi CH Kocken AW Thomas S Dutta DE Lanar E Remarque A Ross TN Williams G Mwambingu B Lowe DJ Conway K Marsh, Vaccine 2004 23 718 728 10.1016/j.vaccine.2004.05.031 15542195
36. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. SD Polley DJ Conway DR Cavanagh JS McBride BS Lowe TN Williams TW Mwangi K Marsh, Vaccine 2006 24 4233 4246 10.1016/j.vaccine.2005.06.030 16111789
37. Does infection with Human Immunodeficiency Virus affect the antibody responses to Plasmodium falciparum antigenic determinants in asymptomatic pregnant women? JG Ayisi OH Branch A Rafi-Janajreh AM van Eijk FO ter Kuile DH Rosen PA Kager DE Lanar A Barbosa D Kaslow BL Nahlen AA Lal, J Infect 2003 46 164 172 10.1053/jinf.2002.1088 12643865
38. Immunological effects of HIV-1 infection on the humoral response to malaria in an African population. F Wabwire-Mangen CJ Shiff D Vlahov R Kline D Serwadda NK Sewankambo RD Mugerwa TC Quinn, Am J Trop Med Hyg 1989 41 504 511 2683820
39. Malaria in pregnancy: pathogenesis and immunity. SJ Rogerson L Hviid PE Duffy RF Leke DW Taylor, Lancet Infect Dis 2007 7 105 117 10.1016/S1473-3099(07) 70022-1 17251081
40. Fcgamma receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro. AE Tebo PG Kremsner AJ Luty, Clin Exp Immunol 2002 130 300 306 10.1046/j.1365-2249.2002.01972.x 12390319
41. Contribution of humoral immunity to the therapeutic response in falciparum malaria. M Mayxay K Chotivanich S Pukrittayakamee P Newton S Looareesuwan NJ White, Am J Trop Med Hyg 2001 65 918 923 11791999
42. Polymerase chain reaction adjustment in antimalarial trials: molecular malarkey? JJ Juliano SM Taylor SR Meshnick, J Infect Dis 2009 200 5 7 10.1086/599379 19469704